Trials / Recruiting
RecruitingNCT07205289
Serum Collection Study for Assay Development
A Phase 1B Open-label Study to Collect Serum Following Vaccination With Killed Whole-cell Pneumococcal Vaccine (Gamma-PN) in Adults for Use in Assay Validation
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- GPN Vaccines · Industry
- Sex
- All
- Age
- 18 Years – 69 Years
- Healthy volunteers
- Accepted
Summary
The study will collect serum from 12 participants vaccinated with Gamma-PN to assist with assay development and validation
Detailed description
The study will collect serum from 12 participants vaccinated with Gamma-PN to assist with assay development and validation Participants will receive a dose of Gamma-PN and serum will be collected pre dose and Day 28
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Gamma-PN | Killed whole-cell pneumococcal vaccine |
Timeline
- Start date
- 2025-10-01
- Primary completion
- 2026-01-01
- Completion
- 2026-06-01
- First posted
- 2025-10-03
- Last updated
- 2025-10-03
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT07205289. Inclusion in this directory is not an endorsement.